Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Safety, Tolerability, Pharmacokinetics and Pharmacodynamics”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Looking for participantsNCT07701954
What this trial is testing

Single Ascending and Multiple Ascending Dose Study of LCA-0061

Who this might be right for
Atopic DiseasePeanut Allergies
Lycia Therapeutics, Inc. 72
Testing effectiveness (Phase 2)Study completedNCT00347139
What this trial is testing

Repeat Doses Of A New Medication (GW642444) In Asthmatic Patients

Who this might be right for
Pulmonary Disease, Chronic Obstructive
GlaxoSmithKline 55
Early research (Phase 1)Study completedNCT03337022
What this trial is testing

Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of CC-90006 in Subjects With Mild to Moderate Plaque-type Psoriasis

Who this might be right for
Psoriasis
Celgene 34
Early research (Phase 1)Active Not RecruitingNCT05614102
What this trial is testing

A First-in-human Study to Learn How Safe the Study Drug BAY2965501 is, Find the Best Dose (Single Drug & Combination), How it Affects the Body, What Maximum Amount Can be Given, How it Moves Into, Through and Out of the Body, How it Acts on Different Tumors in Participants With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors
Bayer 284
Early research (Phase 1)Looking for participantsNCT07184502
What this trial is testing

Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of ZT003 Injection Following Single and Multiple Subcutaneous Administration in Healthy Volunteers/Overweight or Obese Volunteers

Who this might be right for
Healthy
Beijing QL Biopharmaceutical Co.,Ltd 72
Early research (Phase 1)Looking for participantsNCT07431112
What this trial is testing

AIR-001 in Adults With Alpha-1 Antitrypsin Deficiency (AATD)

Who this might be right for
Alpha 1 Antitrypsin Deficiency
AIRNA Corporation 54
Testing effectiveness (Phase 2)Study completedNCT00861809
What this trial is testing

The Effect of Single Doses of the Motilin Receptor Agonist GSK962040 in Type I Diabetic Patients With Gastroparesis

Who this might be right for
Gastroparesis
GlaxoSmithKline 11
Testing effectiveness (Phase 2)Study completedNCT02292654
What this trial is testing

Safety, Tolerability, PK, and Efficacy Evaluation of Repeat Ascending Doses of Olipudase Alfa in Pediatric Patients <18 Years of Age With Acid Sphingomyelinase Deficiency

Who this might be right for
Sphingomyelin Lipidosis
Genzyme, a Sanofi Company 20
Early research (Phase 1)Study completedNCT02039089
What this trial is testing

A Two-Part Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of E2006 in Healthy Japanese and White Subjects

Who this might be right for
Healthy Volunteers
Eisai Inc. 32
Early research (Phase 1)Study completedNCT06548997
What this trial is testing

A Phase I Study of GZR18 Injection in Healthy Subjects

Who this might be right for
Type 2 DiabetesOverweight and Obesity
Gan and Lee Pharmaceuticals, USA 57
Testing effectiveness (Phase 2)Study completedNCT04364269
What this trial is testing

Safety, Tolerability, Pharmacokinetics (PK), Pharmacodynamics (PD) and Preliminary Efficacy of VIT-2763 in β-thalassaemia

Who this might be right for
Beta-ThalassemiaNon-transfusion-dependent Thalassemia
Vifor (International) Inc. 35
Testing effectiveness (Phase 2)Ended earlyNCT05497453
What this trial is testing

Evaluate OTX-2002 in Patients with Hepatocellular Carcinoma and Other Solid Tumor Types Known for Association with the MYC Oncogene

Who this might be right for
Hepatocellular CarcinomaSolid TumorHepatocellular Carcinoma Non-resectable+4 more
Omega Therapeutics 24
Testing effectiveness (Phase 2)UnknownNCT04564937
What this trial is testing

The Study of Drug SCT510A in Patients With Wet Age-related Macular Degeneration (wAMD)

Who this might be right for
Wet Age-related Macular Degeneration
Sinocelltech Ltd. 66
Early research (Phase 1)Study completedNCT05548231
What this trial is testing

LY3437943 in Chinese Participants With Obesity Or Overweight

Who this might be right for
OverweightObesity
Eli Lilly and Company 32
Early research (Phase 1)UnknownNCT04842370
What this trial is testing

Evaluation of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of PHI 101 for the Treatment of AML

Who this might be right for
Relapsed or Refractory Acute Myeloid Leukemia
Seoul National University Hospital 42
Early research (Phase 1)Looking for participantsNCT07501039
What this trial is testing

BLKR201 in Healthy Adult Participants

Who this might be right for
Healthy
Formation Bio, Inc. 128
Early research (Phase 1)Study completedNCT06480981
What this trial is testing

Multiple Ascending Dose Noribogaine PK/PD in Healthy Volunteers

Who this might be right for
Pharmacokinetics
DemeRx NB 55
Early research (Phase 1)Not Yet RecruitingNCT07618156
What this trial is testing

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of KR25102 in Healthy Volunteers

Who this might be right for
Healthy Volunteers (HV)
Jiangxi Kvvit Pharmaceutical Co., Ltd. 83
Testing effectiveness (Phase 2)Study completedNCT02421172
What this trial is testing

Efficacy, Safety, and Pharmacokinetics Study of CJM112 in Hidradenitis Suppurativa Patients

Who this might be right for
Hidradenitis Suppurativa (Acne Inversa)
Novartis Pharmaceuticals 66
Early research (Phase 1)Study completedNCT00958477
What this trial is testing

Determine the Safety, Tolerability, Pharmacokinetics and Dynamic Effects of Different Doses of the Study Drug EMD 525797 in Prostate Cancer

Who this might be right for
Prostate CancerBone Metastases
Merck KGaA, Darmstadt, Germany 26
Next Page